Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al
The trial is led by two Chief Investigators, Professor Philip Newsome at Kings College London and Arun Sanyal at the VCU School of Medicine, United States, and funded by Novo Nordisk
However, in A Diabetes Outcome Progression Trial (ADOPT), metformin exhibited a reduced risk of monotherapy failure compared with the sulfonylurea glibenclamide (known as glyburide in the USA and Canada) and slower rate of loss of beta cell function, although it was inferior to the thiazolidinedione rosiglitazone [20]
Our streamlined process ensures you have access to a potent weight-loss tool with expert support, making it easier for you to achieve your fitness goals
doi: 10.1073/pnas.1530509100 51 ConwayJRLexAGehlenborgN